Phase II study of weekly docetaxel and trastuzumab for patients with HER-2–overexpressing metastatic breast cancer

…, D Booser, LT Guerra, JL Murray, L Pusztai… - Journal of Clinical …, 2002 - ascopubs.org
PURPOSE: To evaluate the safety and efficacy of weekly docetaxel plus trastuzumab in
women with HER-2–overexpressing metastatic breast cancer. Efficacy was correlated with …

Smoking and causes of death among US veterans: 16 years of observation

E Rogot, JL Murray - Public health reports, 1980 - ncbi.nlm.nih.gov
Murray is an epidemiologist, Biometry Branch, National Cancer Institute. Tearsheet
requests to Mr. Rogot. … L.:Epidemiologic studies of Parkinson's disease. Am J Epidemiol …

Ibritumomab tiuxetan radioimmunotherapy for patients with relapsed or refractory non-Hodgkin lymphoma and mild thrombocytopenia: a phase II multicenter trial

…, NL Bartlett, RJ Schilder, JL Murray… - Blood, The Journal …, 2002 - ashpublications.org
Mildly thrombocytopenic patients with relapsed or refractory low-grade non-Hodgkin lymphoma
(NHL) have an increased risk of chemotherapy-induced myelosuppression following …

Safety of yttrium-90 ibritumomab tiuxetan radioimmunotherapy for relapsed low-grade, follicular, or transformed non-Hodgkin's lymphoma

…, GA Wiseman, C Emmanouilides, JL Murray… - Journal of Clinical …, 2003 - ascopubs.org
Purpose: Radioimmunotherapy (RIT) with yttrium-90 ( 90 Y)-labeled anti-CD20 antibody ( 90
Y ibritumomab tiuxetan; Zevalin, IDEC Pharmaceuticals Corporation, San Diego, CA) has a …

[PDF][PDF] Estrogen receptor (ER) mRNA and ER-related gene expression in breast cancers that are 1% to 10% ER-positive by immunohistochemistry

T Iwamoto, D Booser, V Valero, JL Murray, K Koenig… - J Clin Oncol, 2012 - academia.edu
Purpose We examined borderline estrogen receptor (ER)–positive cancers, defined as having
1% to 10% positivity by immunohistochemistry (IHC), to determine whether they show the …

Rab 5 is required for the cellular entry of dengue and West Nile viruses

…, B Sukumaran, U Pal, H Agaisse, JL Murray… - Journal of …, 2007 - Am Soc Microbiol
The mechanisms of cellular entry of dengue and West Nile viruses are not well characterized.
We show that both these viruses enter HeLa cells by clathrin-dependent endocytosis and …

Targeting the PI3K/AKT/mTOR pathway for the treatment of mesenchymal triple-negative breast cancer: evidence from a phase 1 trial of mTOR inhibition in …

…, M Chavez-MacGregor, NK Ibrahim, JL Murray… - JAMA …, 2017 - jamanetwork.com
Importance Triple-negative breast cancer (TNBC) classified by transcriptional profiling as
the mesenchymal subtype frequently harbors aberrations in the phosphoinositide 3-kinase (…

Cationic Liposome-Mediated E1A Gene Transfer to Human Breast and Ovarian Cancer Cells and Its Biologic Effects: A Phase I Clinical Trial

…, P Anklesaria, NK Ibrahim, JL Murray… - Journal of Clinical …, 2001 - ascopubs.org
PURPOSE: Preclinical studies have demonstrated that the adenovirus type 5 E1A gene is
associated with antitumor activities by transcriptional repression of HER-2/neu and induction …

Results of the First Phase I Clinical Trial of the Novel Ii-Key Hybrid Preventive HER-2/neu Peptide (AE37) Vaccine

…, MT Hueman, EA Mittendorf, JL Murray… - Journal of Clinical …, 2008 - ascopubs.org
Purpose HER-2/neu is overexpressed in breast cancer and is the source of immunogenic
peptides. CD4 + T-helper peptides for HER-2/neu are being evaluated in vaccine trials. The …

Rab9 GTPase is required for replication of human immunodeficiency virus type 1, filoviruses, and measles virus

JL Murray, M Mavrakis, NJ McDonald, M Yilla… - Journal of …, 2005 - Am Soc Microbiol
Rab proteins and their effectors facilitate vesicular transport by tethering donor vesicles to
their respective target membranes. By using gene trap insertional mutagenesis, we identified …